Results 131 to 140 of about 4,340 (195)

Adverse drug reaction profiles of histone deacetylase inhibitors. [PDF]

Sci Rep
Begum R, Parsons JL, Jones AM.
europepmc   +1 more source

Applications of Sombor topological indices and entropy measures for QSPR modeling of anticancer drugs: a Python-based methodology. [PDF]

Sci Rep
Kara Y, Sağlam Özkan Y, Bektaş AB, Arockiaraj M.   +3 more
europepmc   +1 more source

Correction: <i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure. [PDF]

Front Toxicol
Xu ZM, Sluka JP, Zhang CC, Knipp G.
europepmc   +1 more source

An Integrated Approach of Proteomic, Cheminformatic, and In Vitro Drug Screening to Identify Potential Therapeutic Targets of <i>Taenia solium</i> Cysticerci Proteases. [PDF]

ACS Omega
Kaur R, Rawat SS, Keshri AK, Arora N, Mehra P, Chaudhary A, Sharma S, Kumar R, Mishra A, Prasad A.   +9 more
europepmc   +1 more source

<i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure. [PDF]

Front Toxicol
Xu ZM, Sluka JP, Zhang CC, Knipp G.
europepmc   +1 more source

In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma. [PDF]

Cancers (Basel)
Smith KH, Trovillion EM, McKinney KQ, Gourabathini P, Wells K, Gandra D, Sholler C, Votruba I, Oesterheld J, Saulnier Sholler GL.   +9 more
europepmc   +1 more source

Comprehensive Analysis of Drug Response using the FLICK Assay. [PDF]

J Vis Exp
Birdsall GA, Lee MJ.
europepmc   +1 more source

A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome. [PDF]

Cancer Chemother Pharmacol
Maher KR, Shafer D, Schaar D, Bandyopadhyay D, Deng X, Wright J, Piekarz R, Rudek MA, Harvey RD, Grant S.   +9 more
europepmc   +1 more source

Targeting the akt/mtor signaling pathway by maprotiline leads to tumor suppression in T-cell lymphoma. [PDF]

Ann Hematol
Li X, Chen J, Zhang R, Zou S, Yang D, Tu W, Xie F, Mu Y.   +7 more
europepmc   +1 more source

Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups. [PDF]

Pharmaceuticals (Basel)
Pires GS, Tolomeu HV, Rodrigues DA, Lima LM, Fraga CAM, Pinheiro PSM.   +5 more
europepmc   +1 more source